PL3393503T3 - Kompozycje - Google Patents
KompozycjeInfo
- Publication number
- PL3393503T3 PL3393503T3 PL16825402T PL16825402T PL3393503T3 PL 3393503 T3 PL3393503 T3 PL 3393503T3 PL 16825402 T PL16825402 T PL 16825402T PL 16825402 T PL16825402 T PL 16825402T PL 3393503 T3 PL3393503 T3 PL 3393503T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/53—Ligases (6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1522541.0A GB201522541D0 (en) | 2015-12-21 | 2015-12-21 | Compositions |
| PCT/EP2016/082155 WO2017108935A1 (en) | 2015-12-21 | 2016-12-21 | Compositions |
| EP16825402.7A EP3393503B1 (en) | 2015-12-21 | 2016-12-21 | Compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3393503T3 true PL3393503T3 (pl) | 2021-03-08 |
Family
ID=55311356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16825402T PL3393503T3 (pl) | 2015-12-21 | 2016-12-21 | Kompozycje |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11839651B2 (pl) |
| EP (1) | EP3393503B1 (pl) |
| JP (1) | JP6873151B2 (pl) |
| CN (1) | CN108430495B (pl) |
| AU (1) | AU2016378304B2 (pl) |
| CA (1) | CA3003392A1 (pl) |
| DK (1) | DK3393503T3 (pl) |
| ES (1) | ES2828657T3 (pl) |
| GB (1) | GB201522541D0 (pl) |
| HU (1) | HUE050837T2 (pl) |
| PL (1) | PL3393503T3 (pl) |
| SG (1) | SG11201804245SA (pl) |
| WO (1) | WO2017108935A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230201316A1 (en) * | 2020-06-08 | 2023-06-29 | Mv Biotherapeutics Sa | Atp-hydrolyzing enzyme useful for treating dysbiosis |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9203506D0 (sv) * | 1992-11-23 | 1992-11-23 | Astra Ab | Virulence-specific bacterial dna sequence |
| CA2345382A1 (en) * | 1998-10-16 | 2000-04-27 | Immunex Corporation | Inhibitors of platelet activation and recruitment |
| WO2003070823A2 (en) * | 2002-02-20 | 2003-08-28 | The General Hospital Corporation | Conjugates comprising a biodegradable polymer and uses therefor |
| EP1733045A4 (en) * | 2004-02-27 | 2008-08-13 | Apt Therapeutics Inc | DESIGN AND THERAPEUTIC USE OF ADPASE-ENHANCED APYRASES |
| US20090297497A1 (en) * | 2004-10-25 | 2009-12-03 | Kishore Bellamkonda K | Methods and compositions for treating nephrogenic diabetes and insipidus |
| WO2008147482A2 (en) * | 2007-02-13 | 2008-12-04 | Northeastern University | Methods and compositions for improving immune responses |
| CA2717166A1 (en) | 2008-03-03 | 2009-09-19 | Converge Biotech Inc. | Methods of modulating t cell-dependent immune responses |
| ES2904911T3 (es) * | 2009-08-20 | 2022-04-06 | Biosceptre Aust Pty Ltd | Anticuerpos anti-receptor P2X7 y fragmentos de los mismos |
| JP5903718B2 (ja) * | 2010-08-09 | 2016-04-13 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Ｈｉｖ−１感染の処置のための方法及び医薬的組成物 |
| US9987336B2 (en) * | 2012-08-10 | 2018-06-05 | Rutgers, The State University Of New Jersey | Attenuating or treating sepsis or septic shock |
| WO2014052848A1 (en) * | 2012-09-28 | 2014-04-03 | The Regents Of The University Of Michigan | Apyrase treatments |
| NZ708065A (en) | 2012-10-29 | 2019-07-26 | Univ Arkansas | Novel mucosal adjuvants and delivery systems |
| US20150265685A1 (en) * | 2014-03-21 | 2015-09-24 | Apt Therapeutics, Inc. | Apyrase therapy for fibroproliferative disorders, pulmonary hypertension, and heart failure |
| CN109072177A (zh) * | 2016-03-16 | 2018-12-21 | 斯波根生物技术公司 | 用于动物健康和水产养殖的融合蛋白、重组细菌和外孢壁片段 |
-
2015
- 2015-12-21 GB GBGB1522541.0A patent/GB201522541D0/en not_active Ceased
-
2016
- 2016-12-21 JP JP2018551519A patent/JP6873151B2/ja active Active
- 2016-12-21 AU AU2016378304A patent/AU2016378304B2/en active Active
- 2016-12-21 US US16/062,300 patent/US11839651B2/en active Active
- 2016-12-21 DK DK16825402.7T patent/DK3393503T3/da active
- 2016-12-21 EP EP16825402.7A patent/EP3393503B1/en active Active
- 2016-12-21 HU HUE16825402A patent/HUE050837T2/hu unknown
- 2016-12-21 ES ES16825402T patent/ES2828657T3/es active Active
- 2016-12-21 CN CN201680075056.0A patent/CN108430495B/zh active Active
- 2016-12-21 CA CA3003392A patent/CA3003392A1/en active Pending
- 2016-12-21 PL PL16825402T patent/PL3393503T3/pl unknown
- 2016-12-21 SG SG11201804245SA patent/SG11201804245SA/en unknown
- 2016-12-21 WO PCT/EP2016/082155 patent/WO2017108935A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016378304A1 (en) | 2018-05-17 |
| DK3393503T3 (da) | 2020-08-31 |
| AU2016378304B2 (en) | 2024-02-08 |
| SG11201804245SA (en) | 2018-07-30 |
| JP6873151B2 (ja) | 2021-05-19 |
| CA3003392A1 (en) | 2017-06-29 |
| JP2019505574A (ja) | 2019-02-28 |
| ES2828657T3 (es) | 2021-05-27 |
| CN108430495A (zh) | 2018-08-21 |
| EP3393503A1 (en) | 2018-10-31 |
| US11839651B2 (en) | 2023-12-12 |
| US20180353600A1 (en) | 2018-12-13 |
| EP3393503B1 (en) | 2020-08-19 |
| HUE050837T2 (hu) | 2021-01-28 |
| CN108430495B (zh) | 2022-03-11 |
| WO2017108935A1 (en) | 2017-06-29 |
| GB201522541D0 (en) | 2016-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL261792B (en) | Preparations | |
| SG11201705415YA (en) | Multi-supplement compositions | |
| IL260933A (en) | Preparations containing tocorsol or its analogues | |
| IL257131A (en) | Preparations | |
| GB201610156D0 (en) | Cliptac compositions | |
| GB201515387D0 (en) | Compositions | |
| GB201501598D0 (en) | Compositions | |
| IL256559B1 (en) | Flinbolin preparations | |
| GB201506827D0 (en) | Composition | |
| GB201505527D0 (en) | Composition | |
| GB201515391D0 (en) | Compositions | |
| GB201506825D0 (en) | Composition | |
| GB201506829D0 (en) | Composition | |
| GB201506830D0 (en) | Composition | |
| SI3349766T1 (sl) | Antihemoragični sestavki | |
| GB201504665D0 (en) | Composition | |
| GB201504307D0 (en) | Composition | |
| GB201622161D0 (en) | Compositions | |
| GB201614799D0 (en) | Compositions | |
| GB201506828D0 (en) | Composition | |
| GB201505520D0 (en) | Composition | |
| GB2538335B (en) | Compositions | |
| GB201509044D0 (en) | Composition | |
| GB201508722D0 (en) | Composition | |
| GB201506826D0 (en) | Composition |